Figure 2From: Regression of orthotopic neuroblastoma in mice by targeting the endothelial and tumor cell compartmentsOrthotopic NB growth in SCID mice. SCID mice carrying orthotopic NB xenotransplants were randomized at an estimated tumor volume of 0.8 ml (â–¡ n = 10, controls; â– n = 23, for CHS 828 treatment). After randomization, mice were treated daily with either vehicle (â–¡ n = 9; 10 days) or with CHS 828 (20 mg/kg; p.o.) for 10 (â– n = 13) or 30 (â– n = 10) days. Mann-Whitney U test was used to evaluate differences between the groups.Back to article page